Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Hug JoshuaDirector | Open-market sale · 10b5-1 plan | SELL | $386K 16.8K sh | Jun 30, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs | Open-market sale · 10b5-1 plan | SELL | $188K 12.8K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 4 | Talasaz AmirAliDirector, Co-Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 111.8K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 4 | Hug JoshuaDirector | Open-market sale · 10b5-1 plan | SELL | $379K 16.8K sh | Jun 30, 2026 traded Jun 30, 2026 |
| 3 | Puri SumeetChief Accounting Officer | Option exercise · 10b5-1 plan | M | — 17.6K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Daunt JohnEVP, Chief Commercial Officer | Option exercise · 10b5-1 plan | M | — 3,287 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Silberman Michael WChief Legal Officer | Option exercise · 10b5-1 plan | M | — 30.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Talasaz AmirAliDirector, Co-Chief Executive Officer | Option exercise · 10b5-1 plan | M | $467K 111.8K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 2 | Talasaz AmirAliDirector, Co-Chief Executive Officer | Option exercise · 10b5-1 plan | M | $598K 143.0K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $100K 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $211K 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Daunt JohnEVP, Chief Commercial Officer | Option exercise · 10b5-1 plan | M | $71K 3,287 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 1 | Daunt JohnEVP, Chief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $1,528 39 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 1 | Bliss KellyPresident, U.S. Group Health | Open-market sale · 10b5-1 plan | SELL | $21K 2,500 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Kroeker NathanCCO and Interim CFO | Option exercise · 10b5-1 plan | M | — 70.6K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $134K 11.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $22K 1,837 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 39.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Morris Matthew ShawnDirector | Option exercise · 10b5-1 plan | M | — 63.2K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,962 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Feider StephenChief Financial Officer | Option exercise · 10b5-1 plan | M | $25K 4,982 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Talasaz AmirAliDirector, Co-Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 143.0K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Feider StephenChief Financial Officer | Option exercise · 10b5-1 plan | M | — 4,896 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 1,336 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | $34K 17.2K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 1,837 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 8,897 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | $820 100 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 1,001 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 11.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Feider StephenChief Financial Officer | Option exercise · 10b5-1 plan | M | — 4,982 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 100 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Morris Matthew ShawnDirector | Option exercise · 10b5-1 plan | M | — 88.1K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Feider StephenChief Financial Officer | Option exercise · 10b5-1 plan | M | $25K 4,896 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 45 | Leatherberry Antoinette ReneeDirector | Open-market sale | SELL | $198 67 sh | Jun 29, 2026 traded Jun 9, 2026 |
| 41 | Locke MistelleDirector | Open-market sale | SELL | $225 76 sh | Jun 29, 2026 traded Jun 9, 2026 |
| 41 | Locke MistelleDirector | Open-market sale | SELL | $72.75 25 sh | Jun 29, 2026 traded Jun 12, 2026 |
| 40 | Locke MistelleDirector | Open-market sale | SELL | $202 31 sh | Jun 29, 2026 traded Jan 16, 2026 |
| 37 | Leatherberry Antoinette ReneeDirector | Open-market sale | SELL | $66.93 23 sh | Jun 29, 2026 traded Jun 12, 2026 |